Pure Bioscience, Inc. (PURE) Reports Q1 Loss of $0.02

Pure Bioscience, Inc. (OTC: PURE) reported Q1 EPS of ($0.02). Revenue for the quarter came in at $489 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• Bernstein SocGen Group Upgrades Whitbread PLC. (WTB:LN) (WTBCF) to Market Perform
• Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance